It should be noted that in a recent study of a larger DLB cohort, including 829 pathologic Lewy body diseases (LBD) patients, another microglial gene variant TREM2 p.R47H was found to associate with disease risk only in those LBD patients with predominant AD pathology, but not in those with low AD pathology [37], indicating lack of a role for this variant in DLB pathophysiology. Here, TREM2 is linked to Lewy body dementia.